SEARCH

SEARCH BY CITATION

References

  • Adachi H., Suzuki T., Abe M. et al. (2003) Molecular characterization of human and rat organic anion transporter OATP-D. Am. J. Physiol. Renal Physiol. 285, F1188F1197.
  • Akanuma S., Hosoya K., Ito S., Tachikawa M., Terasaki T. and Ohtsuki S. (2010) Involvement of multidrug resistance-associated protein 4 in efflux transport of prostaglandin E(2) across mouse blood-brain barrier and its inhibition by intravenous administration of cephalosporins. J. Pharmacol. Exp. Ther. 333, 912919.
  • Alix E., Schmitt C., Strazielle N. and Ghersi-Egea J. F. (2008) Prostaglandin E2 metabolism in rat brain: role of the blood-brain interfaces. Cerebrospinal Fluid Res. 5, 5.
  • Bito L. Z., Davson H. and Hollingsworth J. R. (1976) Facilitated transport of prostaglandins across the blood-cerebrospinal fluid and blood-brain barriers. J. Physiol. 256, 273285.
  • Carasso R. L., Vardi J., Rabay J. M., Zor U. and Streifler M. (1977) Measurement of prostaglandin E2 in cerebrospinal fluid in patients suffering from stroke. J. Neurol. Neurosurg. Psychiatry 40, 967969.
  • Cattori V., van Montfoort J. E., Stieger B., Landmann L., Meijer D. K., Winterhalter K. H., Meier P. J. and Hagenbuch B. (2001) Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Pflugers Arch. 443, 188195.
  • Chaudhry U. A. and Dore S. (2009) Cytosolic prostaglandin E synthase: expression patterns in control and Alzheimer's disease brains. Am. J. Alzheimers Dis. Other Demen. 24, 4651.
  • Chaudhry U. A., Zhuang H., Crain B. J. and Dore S. (2008) Elevated microsomal prostaglandin-E synthase-1 in Alzheimer's disease. Alzheimers Dement. 4, 613.
  • Chaudhry U., Zhuang H. and Dore S. (2010) Microsomal prostaglandin E synthase-2: cellular distribution and expression in Alzheimer's disease. Exp. Neurol. 223, 359365.
  • Craig W. (1984) Pharmacokinetic and experimental data on beta-lactam antibiotics in the treatment of patients. Eur. J. Clin. Microbiol. 3, 575578.
  • Gao W., Schmidtko A., Wobst I., Lu R., Angioni C. and Geisslinger G. (2009) Prostaglandin D2 produced by hematopoietic prostaglandin D synthase contributes to LPS-induced fever. J. Physiol. Pharmacol. 60, 145150.
  • Gordon G. R., Choi H. B., Rungta R. L., Ellis-Davies G. C. and MacVicar B. A. (2008) Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature 456, 745749.
  • Han H., Kim S. G., Lee M. G., Shim C. K. and Chung S. J. (2002) Mechanism of the reduced elimination clearance of benzylpenicillin from cerebrospinal fluid in rats with intracisternal administration of lipopolysaccharide. Drug Metab. Dispos. 30, 12141220.
  • Hosoya K., Hori S., Ohtsuki S. and Terasaki T. (2004) A new in vitro model for blood-cerebrospinal fluid barrier transport studies: an immortalized choroid plexus epithelial cell line derived from the tsA58 SV40 large T-antigen gene transgenic rat. Adv. Drug Deliv. Rev. 56, 18751885.
  • Ikeda-Matsuo Y., Ota A., Fukada T., Uematsu S., Akira S. and Sasaki Y. (2006) Microsomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury. Proc. Natl Acad. Sci. USA 103, 1179011795.
  • Inoue W., Matsumura K., Yamagata K., Takemiya T., Shiraki T. and Kobayashi S. (2002) Brain-specific endothelial induction of prostaglandin E(2) synthesis enzymes and its temporal relation to fever. Neurosci. Res. 44, 5161.
  • Jung K. Y., Takeda M., Shimoda M. et al. (2002) Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1. Life Sci. 70, 18611874.
  • Kanai N., Lu R., Satriano J. A., Bao Y., Wolkoff A. W. and Schuster V. L. (1995) Identification and characterization of a prostaglandin transporter. Science 268, 866869.
  • Khuth S. T., Strazielle N., Giraudon P., Belin M. F. and Ghersi-Egea J. F. (2005) Impairment of blood-cerebrospinal fluid barrier properties by retrovirus-activated T lymphocytes: reduction in cerebrospinal fluid-to-blood efflux of prostaglandin E2. J. Neurochem. 94, 15801593.
  • Kim S. Y., Chang Y. J., Cho H. M., Hwang Y. W. and Moon Y. S. (2009) Non-steroidal anti-inflammatory drugs for the common cold. Cochrane Database Syst. Rev. CD006362.
  • Kimura H., Takeda M., Narikawa S., Enomoto A., Ichida K. and Endou H. (2002) Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J. Pharmacol. Exp. Ther. 301, 293298.
  • Kis B., Isse T., Snipes J. A., Chen L., Yamashita H., Ueta Y. and Busija D. W. (2006) Effects of LPS stimulation on the expression of prostaglandin carriers in the cells of the blood-brain and blood-cerebrospinal fluid barriers. J. Appl. Physiol. 100, 13921399.
  • Kusuhara H., He Z., Nagata Y., Nozaki Y., Ito T., Masuda H., Meier P. J., Abe T. and Sugiyama Y. (2003) Expression and functional involvement of organic anion transporting polypeptide subtype 3 (Slc21a7) in rat choroid plexus. Pharm. Res. 20, 720727.
  • Leggas M., Adachi M., Scheffer G. L. et al. (2004) Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol. Cell. Biol. 24, 76127621.
  • Masuda S., Ibaramoto K., Takeuchi A., Saito H., Hashimoto Y. and Inui K. I. (1999) Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney. Mol. Pharmacol. 55, 743752.
  • Molavi A. (1991) Cephalosporins: rationale for clinical use. Am. Fam. Physician 43, 937948.
  • Mori S., Takanaga H., Ohtsuki S., Deguchi T., Kang Y. S., Hosoya K. and Terasaki T. (2003) Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J. Cereb. Blood Flow Metab. 23, 432440.
  • Murakami M., Naraba H., Tanioka T. et al. (2000) Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275, 3278332792.
  • Murakami M., Nakatani Y., Tanioka T. and Kudo I. (2002) Prostaglandin E synthase. Prostaglandins Other Lipid Mediat. 68–69, 383399.
  • Nagata Y., Kusuhara H., Endou H. and Sugiyama Y. (2002) Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus. Mol. Pharmacol. 61, 982988.
  • Nakano J., Prancan A. V. and Moore S. E. (1972) Metabolism of prostaglandin E 1 in the cerebral cortex and cerebellum of the dog and rat. Brain Res. 39, 545548.
  • Nakashima T., Tomi M., Tachikawa M., Watanabe M., Terasaki T. and Hosoya K. (2005) Evidence for creatine biosynthesis in Muller glia. Glia 52, 4752.
  • Nilwarangkoon S., Anzai N., Shiraya K. et al. (2007) Role of mouse organic anion transporter 3 (mOat3) as a basolateral prostaglandin E2 transport pathway. J. Pharmacol. Sci. 103, 4855.
  • Ogawa M., Suzuki H., Sawada Y., Hanano M. and Sugiyama Y. (1994) Kinetics of active efflux via choroid plexus of beta-lactam antibiotics from the CSF into the circulation. Am. J. Physiol. 266, R392R399.
  • Ohtsuki S., Takizawa T., Takanaga H., Terasaki N., Kitazawa T., Sasaki M., Abe T., Hosoya K. and Terasaki T. (2003) In vitro study of the functional expression of organic anion transporting polypeptide 3 at rat choroid plexus epithelial cells and its involvement in the cerebrospinal fluid-to-blood transport of estrone-3-sulfate. Mol. Pharmacol. 63, 532537.
  • Ohtsuki S., Takizawa T., Takanaga H., Hori S., Hosoya K. and Terasaki T. (2004) Localization of organic anion transporting polypeptide 3 (oatp3) in mouse brain parenchymal and capillary endothelial cells. J. Neurochem. 90, 743749.
  • Reid G., Wielinga P., Zelcer N., van der Heijden I., Kuil A., de Haas M., Wijnholds J. and Borst P. (2003) The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc. Natl Acad. Sci. USA 100, 92449249.
  • Romero S. D., Chyatte D., Byer D. E., Romero J. C. and Yaksh T. L. (1984) Measurement of prostaglandins in the cerebrospinal fluid in cat, dog, and man. J. Neurochem. 43, 16421649.
  • Sakai K., Shimizu H., Koike T., Furuya S. and Watanabe M. (2003) Neutral amino acid transporter ASCT1 is preferentially expressed in L-Ser-synthetic/storing glial cells in the mouse brain with transient expression in developing capillaries. J. Neurosci. 23, 550560.
  • Scheld W. M. (1984) Rationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis. Eur. J. Clin. Microbiol. 3, 579591.
  • Schliamser S. E., Cars O. and Norrby S. R. (1991) Neurotoxicity of beta-lactam antibiotics: predisposing factors and pathogenesis. J. Antimicrob. Chemother. 27, 405425.
  • Sekine T., Watanabe N., Hosoyamada M., Kanai Y. and Endou H. (1997) Expression cloning and characterization of a novel multispecific organic anion transporter. J. Biol. Chem. 272, 1852618529.
  • Sekine T., Cha S. H., Tsuda M., Apiwattanakul N., Nakajima N., Kanai Y. and Endou H. (1998) Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett. 429, 179182.
  • Shiraya K., Hirata T., Hatano R. et al. (2010) A novel transporter of SLC22 family specifically transports prostaglandins and co-localizes with 15-hydroxyprostaglandin dehydrogenase in renal proximal tubules. J. Biol. Chem. 285, 2214122151.
  • Splawinski J. A., Gorka Z., Zacny E. and Wojtaszek B. (1978) Hyperthermic effects of arachidonic acid, prostaglandin E2 and F2alpha in rats. Pflugers Arch. 374, 1521.
  • Sunden Y., Park C. H., Matsuda K., Anagawa A., Kimura T., Ochiai K., Kida H. and Umemura T. (2003) The effects of antipyretics on influenza virus encephalitis in mice and chicks. J. Vet. Med. Sci. 65, 11851188.
  • Suzuki H., Sawada Y., Sugiyama Y., Iga T. and Hanano M. (1985) Saturable transport of cimetidine from cerebrospinal fluid to blood in rats. J. Pharmacobiodyn. 8, 7376.
  • Suzuki H., Sawada Y., Sugiyama Y., Iga T. and Hanano M. (1987) Transport of benzylpenicillin by the rat choroid plexus in vitro. J. Pharmacol. Exp. Ther. 242, 660665.
  • Sweet D. H., Miller D. S., Pritchard J. B., Fujiwara Y., Beier D. R. and Nigam S. K. (2002) Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. J. Biol. Chem. 277, 2693426943.
  • Tachikawa M., Fukaya M., Terasaki T., Ohtsuki S. and Watanabe M. (2004) Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis. Eur. J. Neurosci. 20, 144160.
  • Tachikawa M., Fujinawa J., Takahashi M. et al. (2008a) Expression and possible role of creatine transporter in the brain and at the blood-cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant. J. Neurochem. 107, 768778.
  • Tachikawa M., Kasai Y., Takahashi M., Fujinawa J., Kitaichi K., Terasaki T. and Hosoya K. (2008b) The blood-cerebrospinal fluid barrier is a major pathway of cerebral creatinine clearance: involvement of transporter-mediated process. J. Neurochem. 107, 432442.
  • Tachikawa M., Tsuji K., Yokoyama R., Higuchi T., Ozeki G., Yashiki A., Akanuma S., Hayashi K., Nishiura A. and Hosoya K. (2012) A clearance system for prostaglandin D2, a sleep-promoting factor, in the cerebrospinal fluid: role of the blood-cerebrospinal barrier transporters. J. Pharmacol. Exp. Ther. doi:10.1124/jpet.112.197012. (in press).
  • Takeda M., Babu E., Narikawa S. and Endou H. (2002) Interaction of human organic anion transporters with various cephalosporin antibiotics. Eur. J. Pharmacol. 438, 137142.
  • Vazquez-Tello A., Fan L., Hou X., Joyal J. S., Mancini J. A., Quiniou C., Clyman R. I., Gobeil Jr F., Varma D. R. and Chemtob S. (2004) Intracellular-specific colocalization of prostaglandin E2 synthases and cyclooxygenases in the brain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R1155R1163.
  • de Waart D. R., Paulusma C. C., Kunne C. and Oude Elferink R. P. (2006) Multidrug resistance associated protein 2 mediates transport of prostaglandin E2. Liver Int. 26, 362368.
  • Walters H. C., Craddock A. L., Fusegawa H., Willingham M. C. and Dawson P. A. (2000) Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G1188G1200.
  • Wijnholds J., deLange E. C., Scheffer G. L., van den Berg D. J., Mol C. A., van d. V. M., Schinkel A. H., Scheper R. J., Breimer D. D. and Borst P. (2000) Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J. Clin. Invest. 105, 279285.
  • Yamagata K., Matsumura K., Inoue W., Shiraki T., Suzuki K., Yasuda S., Sugiura H., Cao C., Watanabe Y. and Kobayashi S. (2001) Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J. Neurosci. 21, 26692677.
  • Yamaoka K., Tanaka H., Okumura K., Yasuhara M. and Hori R. (1986) An analysis program MULTI(ELS) based on extended nonlinear least squares method for microcomputers. J. Pharmacobiodyn. 9, 161173.